{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T23:30:30Z","timestamp":1775950230972,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1038\/ja.2012.62","type":"journal-article","created":{"date-parts":[[2012,8,6]],"date-time":"2012-08-06T11:37:13Z","timestamp":1344253033000},"page":"505-508","source":"Crossref","is-referenced-by-count":21,"title":["In vitro susceptibility of Staphylococcus aureus and Staphylococcus epidermidis isolated from prosthetic joint infections"],"prefix":"10.1038","volume":"65","author":[{"given":"Diana","family":"Molina-Manso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gema","family":"del Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Ortiz-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Manrubia-Cobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"G\u00f3mez-Barrena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Cordero-Ampuero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,1]]},"reference":[{"key":"BFja201262_CR1","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1086\/374554","volume":"36","author":"JR Lentino","year":"2003","unstructured":"Lentino, J. R. Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clin. Infect. Dis. 36, 1157\u20131161 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"BFja201262_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.7150\/ijms.6.227","volume":"6","author":"K Anagnostakos","year":"2009","unstructured":"Anagnostakos, K., Schmid, N. V., Kelm, J., Grun, U. & Jung, J. Classification of hip joint infections. Int. J. Med. Sci. 6, 227\u2013233 (2009).","journal-title":"Int. J. Med. Sci."},{"key":"BFja201262_CR3","first-page":"243","volume":"135","author":"A Trampuz","year":"2005","unstructured":"Trampuz, A. & Zimmerli, W. Prosthetic joint infections: update in diagnosis and treatment. Swiss Med. Wkly. 135, 243\u2013251 (2005).","journal-title":"Swiss Med. Wkly."},{"key":"BFja201262_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/jac\/dkh033","volume":"53","author":"L Bernard","year":"2004","unstructured":"Bernard, L. et al. Trends in the treatment of orthopaedic prosthetic infections. J. Antimicrob. Chemother. 53, 127\u2013129 (2004).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja201262_CR5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.7150\/ijms.6.234","volume":"6","author":"U Geipel","year":"2009","unstructured":"Geipel, U. Pathogenic organisms in hip joint infections. Int. J. Med. Sci. 6, 234\u2013240 (2009).","journal-title":"Int. J. Med. Sci."},{"key":"BFja201262_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1056\/NEJMcp0905029","volume":"361","author":"JL Del Pozo","year":"2009","unstructured":"Del Pozo, J. L. & Patel, R. Clinical practice. Infection associated with prosthetic joints. N. Engl. J. Med. 361, 787\u2013794 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFja201262_CR7","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1007\/s11999-009-0857-z","volume":"467","author":"J Parvizi","year":"2009","unstructured":"Parvizi, J., Azzam, K., Ghanem, E., Austin, M. S. & Rothman, R. H. Periprosthetic infection due to resistant staphylococci: serious problems on the horizon. Clin. Orthop. Relat. Res. 467, 1732\u20131739 (2009).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"BFja201262_CR8","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1128\/JCM.02098-09","volume":"48","author":"J Cremniter","year":"2010","unstructured":"Cremniter, J. et al. Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device-associated infections. J. Clin. Microbiol. 48, 1428\u20131431 (2010).","journal-title":"J. Clin. Microbiol."},{"key":"BFja201262_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ijantimicag.2010.10.029","volume":"37","author":"SP Hawser","year":"2011","unstructured":"Hawser, S. P., Bouchillon, S. K., Hoban, D. J., Dowzicky, M. & Babinchak, T. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009. Int. J. Antimicrob. Agents 37, 219\u2013224 (2011).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"BFja201262_CR10","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s00402-008-0772-x","volume":"129","author":"DA Rice","year":"2009","unstructured":"Rice, D. A. & Mendez-Vigo, L. Daptomycin in bone and joint infections: a review of the literature. Arch. Orthop. Trauma Surg. 129, 1495\u20131504 (2009).","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"BFja201262_CR11","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1128\/AAC.37.6.1214","volume":"37","author":"M Drancourt","year":"1993","unstructured":"Drancourt, M. et al. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob. Agents Chemother. 37, 1214\u20131218 (1993).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja201262_CR12","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1128\/AAC.42.12.3086","volume":"42","author":"A Stein","year":"1998","unstructured":"Stein, A. et al. Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob. Agents Chemother. 42, 3086\u20133091 (1998).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja201262_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1128\/AAC.50.1.55-61.2006","volume":"50","author":"R Saginur","year":"2006","unstructured":"Saginur, R. et al. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob. Agents Chemother. 50, 55\u201361 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja201262_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5507\/bp.2005.019","volume":"149","author":"J Gallo","year":"2005","unstructured":"Gallo, J. et al. In vitro testing of gentamicin-vancomycin loaded bone cement to prevent prosthetic joint infection. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech Repub 149, 153\u2013158 (2005).","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech Repub"},{"key":"BFja201262_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/jac\/dki016","volume":"55","author":"M Bassetti","year":"2005","unstructured":"Bassetti, M. et al. Linezolid in the treatment of Gram-positive prosthetic joint infections. J. Antimicrob. Chemother. 55, 387\u2013390 (2005).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFja201262_CR16","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1517\/14656566.2011.543676","volume":"12","author":"J Esteban","year":"2011","unstructured":"Esteban, J. & Cordero-Ampuero, J. Treatment of prosthetic osteoarticular infections. Expert Opin. Pharmacother. 12, 899\u2013912 (2011).","journal-title":"Expert Opin. Pharmacother."},{"key":"BFja201262_CR17","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1046\/j.1365-2958.2003.03493.x","volume":"48","author":"J Valle","year":"2003","unstructured":"Valle, J. et al. SarA and not sigmaB is essential for biofilm development by Staphylococcus aureus. Mol. Microbiol. 48, 1075\u20131087 (2003).","journal-title":"Mol. Microbiol."},{"key":"BFja201262_CR18","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1128\/JCM.01762-07","volume":"46","author":"J Esteban","year":"2008","unstructured":"Esteban, J. et al. Evaluation of quantitative analysis of cultures from sonicated retrieved orthopedic implants in diagnosis of orthopedic infection. J. Clin Microbiol. 46, 488\u2013492 (2008).","journal-title":"J. Clin Microbiol."},{"key":"BFja201262_CR19","unstructured":"CLSI Performance Standards for Antimicrobial Susceptibility Testing. Twenty-first informational supplement In M100-S21 Vol 31 No 1 (2012)."},{"key":"BFja201262_CR20","unstructured":"EUCAST Breakpoint tables for interpretation of MICs and zone diameters In Version 2.0 (2012)."},{"key":"BFja201262_CR21","first-page":"102","volume-title":"Antibiotics in Laboratory Medicine","author":"D Amsterdam","year":"1996","unstructured":"Amsterdam, D. Susceptibility testing of antimicrobials in liquid media In Antibiotics in Laboratory Medicine (Ed., V.L.) 102\u2013103 Williams & Wilkins: Philadelphia, (1996)."},{"key":"BFja201262_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1469-0691.2006.01343.x","volume":"12","author":"GC Schito","year":"2006","unstructured":"Schito, G. C. The importance of the development of antibiotic resistance in Staphylococcus aureus. Clin. Microbiol. Infect. 12 (Suppl 1) 3\u20138 (2006).","journal-title":"Clin. Microbiol. Infect."},{"key":"BFja201262_CR23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1469-0691.2006.01573.x","volume":"13","author":"RH Deurenberg","year":"2007","unstructured":"Deurenberg, R. H. et al. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 13, 222\u2013235 (2007).","journal-title":"Clin. Microbiol. Infect."},{"key":"BFja201262_CR24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ijantimicag.2007.10.026","volume":"31","author":"C von Eiff","year":"2008","unstructured":"von Eiff, C. Staphylococcus aureus small colony variants: a challenge to microbiologists and clinicians. Int. J. Antimicrob. Agents 31, 507\u2013510 (2008).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"BFja201262_CR25","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1086\/592973","volume":"47","author":"P Schafer","year":"2008","unstructured":"Schafer, P. et al. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clin. Infect. Dis. 47, 1403\u20131409 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"BFja201262_CR26","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1086\/507643","volume":"43","author":"P Vaudaux","year":"2006","unstructured":"Vaudaux, P., Kelley, W. L. & Lew, D. P. Staphylococcus aureus small colony variants: difficult to diagnose and difficult to treat. Clin. Infect. Dis. 43, 968\u2013970 (2006).","journal-title":"Clin. Infect. Dis."},{"key":"BFja201262_CR27","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1086\/507633","volume":"43","author":"P Sendi","year":"2006","unstructured":"Sendi, P. et al. Staphylococcus aureus small colony variants in prosthetic joint infection. Clin. Infect. Dis. 43, 961\u2013967 (2006).","journal-title":"Clin. Infect. Dis."},{"key":"BFja201262_CR28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ajic.2005.06.006","volume":"33","author":"EV Kourbatova","year":"2005","unstructured":"Kourbatova, E. V. et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am. J. Infect. Control\\ 33, 385\u2013391 (2005).","journal-title":"Am. J. Infect. Control\\"},{"key":"BFja201262_CR29","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1128\/JCM.01579-08","volume":"47","author":"A Vindel","year":"2009","unstructured":"Vindel, A. et al. Methicillin-resistant Staphylococcus aureus in Spain: molecular epidemiology and utility of different typing methods. J. Clin. Microbiol. 47, 1620\u20131627 (2009).","journal-title":"J. Clin. Microbiol."},{"key":"BFja201262_CR30","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1128\/CMR.15.3.430-438.2002","volume":"15","author":"A Srinivasan","year":"2002","unstructured":"Srinivasan, A., Dick, J. D. & Perl, T. M. Vancomycin resistance in staphylococci. Clin. Microbiol. Rev. 15, 430\u2013438 (2002).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFja201262_CR31","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","volume":"279","author":"W Zimmerli","year":"1998","unstructured":"Zimmerli, W., Widmer, A. F., Blatter, M., Frei, R. & Ochsner, P. E. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 279, 1537\u20131541 (1998).","journal-title":"JAMA"},{"key":"BFja201262_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.diagmicrobio.2011.02.009","volume":"70","author":"JJ Picazo","year":"2011","unstructured":"Picazo, J. J. et al. Comparative activities of daptomycin and several agents against staphylococcal blood isolates. Glycopeptide tolerance. Diagn. Microbiol. Infect. Dis. 70, 373\u2013379 (2011).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"BFja201262_CR33","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1128\/AAC.01491-05","volume":"50","author":"HS Sader","year":"2006","unstructured":"Sader, H. S., Fritsche, T. R. & Jones, R. N. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. Antimicrob. Agents Chemother. 50, 2330\u20132336 (2006).","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ja201262.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ja201262","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ja201262.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:18:44Z","timestamp":1684430324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ja201262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,1]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["BFja201262"],"URL":"https:\/\/doi.org\/10.1038\/ja.2012.62","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,1]]}}}